ANPCF OTC
Cellbxhealth PLC
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +18.4%
1Y: -58.3%
3Y: -98.5%
5Y: -97.3%
$0.02
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$3M
+30.9% ▲
5Y CAGR: +26.8%
Gross Profit
$2M
+536.0% ▲
Operating Income
-$15M
+30.6% ▲
Net Income
-$14M
+29.3% ▲
EPS (Diluted)
$-0.05
+37.6% ▲
EBITDA
-$13M
+31.4% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|---|
| Revenue | $762K | $1M | $1M | $2M | $3M |
| YoY Growth | -12.6% | +32.9% | +2.8% | +110.0% | +30.9% |
| Cost of Revenue | $165K | $302K | $428K | $3M | $1M |
| Gross Profit | $597K | $711K | $613K | -$408K | $2M |
| Gross Margin | 78.3% | 70.2% | 58.9% | -18.7% | 62.2% |
| R&D Expenses | $8M | $8M | $11M | $10M | $2M |
| SG&A Expenses | $372K | $342K | $557K | $382K | $455K |
| Operating Expenses | $14M | $18M | $25M | $21M | $17M |
| Operating Income | -$14M | -$17M | -$24M | -$22M | -$15M |
| Operating Margin | -1802.0% | -1701.4% | -2325.4% | -995.4% | -527.5% |
| Interest Expense | $92K | $157K | $354K | $325K | $307K |
| Income Before Tax | -$14M | -$17M | -$24M | -$22M | -$15M |
| Tax Expense | -$2M | -$2M | -$3M | -$2M | -$804K |
| Net Income | -$12M | -$15M | -$22M | -$20M | -$14M |
| Net Margin | -1523.1% | -1481.9% | -2083.2% | -921.0% | -497.0% |
| EPS (Diluted) | $-0.07 | $-0.07 | $-0.09 | $-0.08 | $-0.05 |
| EBITDA | -$12M | -$16M | -$24M | -$19M | -$13M |
| Shares Outstanding | 178M | 225M | 247M | 260M | 295M |